Being an NMDP/Be The Match courier during COVID-19

Making essential treatments possible in the midst of a pandemic

Overcoming autologous cell therapy logistics challenges in the age of COVID-19

Experienced team for managed logistics is key

Can cell therapies unlock the COVID-19 mystery?

The promise of MSC therapies to treat deadly manifestations of cytokine storms

How COVID-19 is changing the production of cell therapies

Implementation of contingency plans allows for continued progress in therapy development

Managing donor collections during the COVID-19 pandemic

Why a diverse apheresis center network is critical to business continuity

Navigating a time-sensitive cell therapy supply chain during the coronavirus outbreak (Updated)

Why established systems and relationships matter